Biodexa Pharmaceuticals PLC - American Depositary Shares (BDRX) closed at $2.41 on November 5, 2026, down 10.4% from the previous close, on volume of 22,344 shares (30-day average 2,791,784).
Data as of November 5, 2026.
Short Interest Alert: Most and least shorted sub-$2B healthcare stock at the end of October
Seeking Alpha News (Tue, 3-Nov 10:15 AM ET)
Globe Newswire (Tue, 13-Oct 8:30 AM ET)
The Longview: Fireside Chat with Biodexa CEO Stephen Stamp
ACCESS Newswire (Wed, 23-Sep 6:30 AM ET)
Biodexa Enters Into Warrant Exercise Transaction for $2.3 Million in Gross Proceeds
Globe Newswire (Tue, 15-Sep 8:00 AM ET)
Interim results for the six months ended June 30, 2026
Globe Newswire (Fri, 11-Sep 4:30 PM ET)
Biodexa announces major milestone for its Serenta registrational Phase 3 trial in FAP
Globe Newswire (Wed, 19-Aug 8:30 AM ET)
Market Chameleon (Thu, 2-Apr 5:53 AM ET)
Market Chameleon (Thu, 18-Dec 4:37 AM ET)
Market Chameleon (Mon, 3-Nov 3:50 AM ET)
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.
Biodexa Pharmaceuticals PLC - American Depositary Shares trades on the NASDAQ stock market under the symbol BDRX.
As of November 6, 2026, BDRX stock price climbed to $2.45 with 10,343 million shares trading.
BDRX has a beta of 2.62, meaning it tends to be more sensitive to market movements. BDRX has a correlation of 0.06 to the broad based SPY ETF.
BDRX has a market cap of $2.52 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, BDRX traded as high as $88,100.01 and as low as $2.28.
BDRX has underperformed the market in the last year with a price return of -98.9% while the SPY ETF gained +10.0%. BDRX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -80.7% and -26.0%, respectively, while the SPY returned -3.9% and -3.4%, respectively.
BDRX support price is $2.10 and resistance is $2.72 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BDRX shares will trade within this expected range on the day.
